Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma.
Corazzelli
Gaetano
G
De Filippi
Rosaria
R
Capobianco
Gaetana
G
Frigeri
Ferdinando
F
De Rosa
Vincenzo
V
Iaccarino
Giancarla
G
Russo
Filippo
F
Arcamone
Manuela
M
Becchimanzi
Cristina
C
Crisci
Stefania
S
Marcacci
Gianpaolo
G
Amoroso
Barbara
B
Lastoria
Secondo
S
Pinto
Antonio
A
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D057176:Compassionate Use Trials; D006689:Hodgkin Disease / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D000077269:Lenalidomide; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide